Molecular and cellular mechanisms in diabetic heart failure: Potential therapeutic targets

Misganaw Asmamaw Mengstie1, Endeshaw Chekol Abebe1, Awgichew Behaile Teklemariam1

  • 1Department of Biochemistry, College of Medicine and Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.

Frontiers in Endocrinology
|September 19, 2022
PubMed

Insights

Diabetes Mellitus (DM) significantly increases heart failure risk, even without other risk factors. This review explores the cellular and molecular mechanisms driving diabetes-induced heart failure to inform new therapeutic strategies.

Area of Science:

  • Cardiology
  • Endocrinology
  • Molecular Biology

Background:

  • Diabetes Mellitus (DM) is a global health concern linked to severe complications.
  • Diabetic heart failure (HF) contributes significantly to morbidity and mortality worldwide.
  • HF in DM patients often occurs independently of hypertension or coronary artery disease.

Purpose of the Study:

  • To review current knowledge on diabetes-induced heart failure.
  • To summarize recent findings on the cellular and molecular mechanisms involved.
  • To provide insights for developing novel therapeutics.

Main Methods:

  • Literature review of existing studies.
  • Synthesis of current research on diabetes-induced heart failure.
  • Analysis of cellular and molecular alterations in diabetic hearts.

Main Results:

  • Diabetes induces heart failure through complex cellular and molecular pathways.
  • Mechanisms include metabolic dysregulation, oxidative stress, and inflammation.
  • Understanding these pathways is crucial for targeted interventions.

Conclusions:

  • Diabetes is an independent risk factor for heart failure.
  • Further research into molecular mechanisms can guide the development of preventative and therapeutic strategies.
  • Targeting diabetes-specific pathways offers promise for managing diabetic cardiomyopathy.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
489
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
459
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
21
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K